Zinc Finger Protein-Like 1: Potential Drug Targets and Biomarkers
Zinc Finger Protein-Like 1: Potential Drug Targets and Biomarkers
Zinc Finger Protein-Like 1 (ZFPL1) is a protein that is expressed in a wide range of tissues in the human body, including the brain, heart, and gastrointestinal tract. It is characterized by the presence of a zinc finger domain, which is a common structural feature that is found in many proteins that play important roles in various biological processes.
One of the unique features of ZFPL1 is its ability to interact with other proteins, particularly those that are involved in signaling pathways that are important for brain development and function. This interaction between ZFPL1 and other proteins has led to its potential as a drug target or biomarker.
In recent years, research has focused on the role of ZFPL1 in various biological processes, including cell signaling, neurodegeneration, and disease. One of the most significant findings related to ZFPL1 is its involvement in the development and progression of Alzheimer's disease.
Studies have shown that ZFPL1 is expressed in the brains of individuals with Alzheimer's disease and that it is associated with the progression of the disease. Additionally, research has found that inhibiting the activity of ZFPL1 using small molecules has the potential to treat Alzheimer's disease.
Another area of research related to ZFPL1 is its potential as a biomarker for cancer. Several studies have shown that ZFPL1 is expressed in various types of cancer, including breast, lung, and ovarian cancer. Additionally, research has found that ZFPL1 is associated with the development and progression of cancer.
The potential drug targets for ZFPL1 are vast, and there are several different approaches that researchers are exploring to exploit its potential. One approach is to use small molecules to inhibit the activity of ZFPL1, which could be a treatment for a variety of diseases. Another approach is to use ZFPL1 as a biomarker to diagnose and monitor the progression of disease.
In conclusion, Zinc Finger Protein-Like 1 (ZFPL1) is a protein that is characterized by the presence of a zinc finger domain and is expressed in a wide range of tissues in the human body. Its interaction with other proteins has led to its potential as a drug target or biomarker, particularly in the development and progression of Alzheimer's disease and cancer. Further research is needed to fully understand the role of ZFPL1 in various biological processes and to explore its potential as a treatment or biomarker.
Protein Name: Zinc Finger Protein Like 1
Functions: Required for cis-Golgi integrity and efficient ER to Golgi transport. Involved in the maintenance of the integrity of the cis-Golgi, possibly via its interaction with GOLGA2/GM130
More Common Targets
ZFPM1 | ZFPM2 | ZFPM2-AS1 | ZFR | ZFR2 | ZFTA | ZFTRAF1 | ZFX | ZFX-AS1 | ZFY | ZFYVE1 | ZFYVE16 | ZFYVE19 | ZFYVE21 | ZFYVE26 | ZFYVE27 | ZFYVE28 | ZFYVE9 | ZFYVE9P1 | ZG16 | ZG16B | ZGLP1 | ZGPAT | ZGRF1 | ZHX1 | ZHX1-C8orf76 | ZHX2 | ZHX3 | ZIC1 | ZIC2 | ZIC3 | ZIC4 | ZIC5 | ZIK1 | ZIM2 | ZIM3 | Zinc finger protein GLI | ZKSCAN1 | ZKSCAN2 | ZKSCAN3 | ZKSCAN4 | ZKSCAN5 | ZKSCAN7 | ZKSCAN8 | ZKSCAN8P1 | ZMAT1 | ZMAT2 | ZMAT3 | ZMAT4 | ZMAT5 | ZMIZ1 | ZMIZ1-AS1 | ZMIZ2 | ZMPSTE24 | ZMYM1 | ZMYM2 | ZMYM3 | ZMYM4 | ZMYM4-AS1 | ZMYM5 | ZMYM6 | ZMYND10 | ZMYND11 | ZMYND12 | ZMYND15 | ZMYND19 | ZMYND8 | ZNF10 | ZNF100 | ZNF101 | ZNF106 | ZNF107 | ZNF112 | ZNF114 | ZNF117 | ZNF12 | ZNF121 | ZNF124 | ZNF131 | ZNF132 | ZNF133 | ZNF134 | ZNF135 | ZNF136 | ZNF137P | ZNF138 | ZNF14 | ZNF140 | ZNF141 | ZNF142 | ZNF143 | ZNF146 | ZNF148 | ZNF154 | ZNF155 | ZNF157 | ZNF16 | ZNF160 | ZNF165 | ZNF169
